Anxiolytic-like profile of p-MPPI, a novel 5HT(1A) receptor antagonist, in the murine elevated plus-maze

Psychopharmacology

Volumn 129, Issue 4, 1997, Pages 365-371

  Cao, B J ^a   Rodgers, R J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

5 HT(1A) receptors; Anxiety; Elevated plus maze; Mice; p MPPI

Indexed keywords

4 (2' METHOXYPHENYL) 1 [2' (2'' PYRIDINYL) 4 IODOBENZAMIDO] ETHYLPIPERAZINE; ANXIOLYTIC AGENT; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; BEHAVIOR; CONTROLLED STUDY; ETHOLOGY; GROOMING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; MOTOR ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; TRANQUILIZING ACTIVITY;

AMINOPYRIDINES; ANIMALS; ANXIETY; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MAZE LEARNING; MICE; PIPERAZINES; SEROTONIN ANTAGONISTS;

EID: 0031057229     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050202     Document Type: Article

References (54)

1. 1A receptors. Soc Neurosci Abstr 20:1542
2. 1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively. Eur J Pharmacol 264:259-264
3. 1A receptors as targets for the development of novel anxiolytic drgus: models, mechanisms and further directions. Psychopharmacology 112:1-12
4. 1A receptor antagonists (+) WAY 100135 and WAY 100635. Neuropharmacology 34:805-811
5. 1A receptor ligands in the mouse. Br J Pharmacol 111:151P
6. 1A receptor antagonist (S)-fluoro-8-hydroxy-2-(dipropylamino) tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects. J Pharmacol Exp Ther 258:58-65
7. Cadogan AK, Kendall DA, Fink H, Marsden CA (1994) Social interaction increases 5-HT release and cAMP efflux in the rat ventral hippocampus in vivo. Behav Pharmacol 5: 299-305
8. Cao B-J, Rodgers RJ (1996a) Different behavioural profiles of R(+)-and S(-)-enantiomers of 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) in the murine elevated plus-maze. Behav Pharmacol 7 (in press)
9. 1A. Pharmacol Biochem Behav (in press).
10. 1A receptor antagonism on plus-maze behaviour in mice. II. WAY 100635, SDZ 216-525 and NAN 190. Pharmacol Biochem Behav (in press).
11. 3) receptor anagonists increase rates of punished responding in rats. Pharmacol Biochem Behav 52:621-676
12. 1A receptor ligands on a safety signal withdrawal procedure of conflict in the rat. Pharmacol Biochem Behav 48:281-289
13. 1A receptor antagonists. Curr Drugs: Serotonin 1:99-124
14. Cole JC, Rodgers RJ (1993) An ethological analysis of the effects of chloridazpoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze. Behav Pharmacol 4:573-580
15. Cole JC, Rodgers RJ (1994) Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol. Psychopharmacology 114:288-296
16. Cole JC, Rodgers RJ (1995) Ethological comparison of the effects of diazepam and acture/chronic imipramine on the behaviour of mice in the elevated plus-maze. Pharmacol Biochem Behav 52:473-478
17. 1A antagonist. WAY100635. J Psychopharmacol 10:A46
18. 1A receptors that are negatively coupled to adenylate cyclase. Mol Pharmacol 39: 780-787
19. 1A receptor agonists: recent developments and controversial issues. Psychopharmacology 121: 1-26
20. 1A receptors. Ellis Horwood, Chichester, pp 261-277
21. File SE, Zangrossi H, Andrews N (1993) Social interaction and elevated plus-maze tests: changes in release and uptake of 5-HT and GABA. Neuropharmacology 32:217-221
22. 1A receptor modulation of anxiety in two ethological animal tests. J Neurosci 16: 4810-4815
23. 1A antagonist WAY 100135. Presented at 2nd International Symposium on Serotonin: from Cell Biology to Pharmacology and Therapeutics Houston, September 15-18 (Abstract Book), p 30
24. 1A receptor antagonists: utility as research tools and therapeutic agents. Trends Pharmacol Sci 14:441-448
25. 1A receptor antagonist. Behav Brain Res 73:337-353
26. Fornal C, Metzler CW, Veasey SC, McCreary AC, Dourish CT, Jacobs BL (1994) Single unit recordings from freely-moving animals provide evidence that WAY 100635, but not (S)-WAY 100135, blocks the action of endogenous serotonin at the 5-HT receptor. Br J Pharmacol 112:92P
27. 1A receptor antagonist, WAY 100635. Eur J Pharmacol 281:81-88
28. Griebel G (1995) 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol Ther 65:319-395
29. 1A receptor antagonist has anxiogenic effects in rats and does not block stress-induced rises in stress hormones. Soc Neurosci Abstr 21:1366
30. 1A antagonist is determined by aroustal state. J Psychopharmacol 8:A13
31. Handley SL (1995) 5-Hydroxytryptamine pathways in anxiety and its treatment. Pharmacol Ther 66:103-148
32. Iversen SD (1984) 5-HT and anxiety. Neuropharmacology 23: 1553-1560
33. 1A receptor antagonist: p-MPPI. Life Sci 55: 1459-1462
34. 1A receptors in rat brain. Synapse 18:359-366
35. 1A receptor antagonist: MPPI. Soc Neurosci Abstr 20:1542
36. 125I] p-MPPI) as a new selective radioligand of serotonin-1A sites in rat brain: In vitro binding and autoradiographic studies. J Pharmacol Exp Ther 272:429-437
37. Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180-185
38. 1A receptor antagonist (S)-UH-301 in rodents and monkeys. Brain Res Bull 29: 901-904
39. Murphy DL, Lesch KP, Aulakh CS, Pigott TA (1991) Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans. Pharmacol Rev 43:527-552
40. Norman TR, Judd FK (1989) Panic attacks, buspirone and serotonin function. Lancet 2:615
41. 1A) receptors in the anticonflict activity of β-adrenoceptor antagonists. Neuropharmacology 34:1211-1217
42. Rodgers RJ, Cole JC (1994a) The elevated plus-maze: pharmacology, methodology and ethology. In: Cooper SJ, Hendrie CA (eds) Ethology and psychopharmacology. Wiley, Chichester, pp 9-44
43. 1A receptor antagonist, in the murine elevated plus-maze test. Eur J Pharmacol 261:321-325
44. Rodgers RJ, Johnson NJT (1995) Factor analysis of spatiotemporal and ethological measures in the elevated plus-maze test of anxiety. Pharmacol Biochem Behav 52:297-303
45. Rodgers RJ, Cole JC, Cobain MR, Daly P, Doran PJ, Eells JR, Wallis P (1992) Anxiogenic-like effects of fluprazine and etoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP. Behav Pharmacol 3:621-634
46. 1A receptor agonist, flesinoxan. Pharmacol Biochem Behav 48:959-963
47. 1A receptor antagonists. Behav Brain Res 73:153-156
48. 1A receptor activation in vivo. Soc Neurosci Abstr 20:1542
49. 1A receptor activation in vivo. Life Sci 56:163-168
50. 1A receptor antagonists. Soc Neurosci Abstr 21:1368
51. Thielen RJ, Fangon NB, Frazer A (1996) 4-(2′-Methoxy-phenyl)-1-[2′-N-2″-pyridinyl)-p-iodobenzamido]- ethyl-piperazine and 4-(2′-methoxy-phenyl)-1-[2′-(N-2″-pyridinyl)-p- fluorobenzamido]-ethyl-piperazine two new antagonists at pre- and postsynaptic serotonin-1A receptors. J Pharmacol Exp Ther 277:661-670
52. Treit D, Menard J, Royan C (1993) Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44: 463-469
53. Wright IK, Upton N, Marsden CA (1992) Effects of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze. Psychopharmacology 109:338-346
54. 1A ligand. J Med Chem 37:1406-1407